EUVIMED · CrossrefJournal
Nature Clinical Practice Oncology
ISSN 1743-4254 · Springer Science and Business Media LLC
Latest articles
New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer
Response criteria for glioma
Therapy Insight: management of cardiovascular disease in patients with cancer and cardiac complications of cancer therapy
Mechanisms of Disease: signal transduction in lung carcinogenesis—a comparison of smokers and never-smokers
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
The impact of histopathologic diagnosis on the proper management of testis neoplasms
Do stress-related psychosocial factors contribute to cancer incidence and survival?
Mechanisms of Disease: temozolomide and glioblastoma—look to the future
Therapy Insight: anthracyclines and trastuzumab—the optimal management of cardiotoxic side effects
Rapamycin treatment for a child with germline PTEN mutation
Angiogenesis as a strategic target for ovarian cancer therapy
Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs
Ovarian cancer: challenges of early detection
Interleukin 2 for patients with renal cancer
Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer
Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification
Drug Insight: role of the androgen receptor in the development and progression of prostate cancer
Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress
Interferon β adenoviral gene therapy in a patient with ovarian cancer
Mechanisms of Disease: oncogene addiction—a rationale for molecular targeting in cancer therapy
Bortezomib: efficacy comparisons in solid tumors and hematologic malignancies
Mechanisms of Disease: understanding resistance to HER2-targeted therapy in human breast cancer
DNA methylation and gene silencing in cancer
Angiogenic inhibitors: a new therapeutic strategy in oncology
Cancer chemoprevention: scientific promise, clinical uncertainty
Primer: an evidence-based approach to prognostic markers
Mechanisms of Disease: insights into the emerging role of signal transducers and activators of transcription in cancer
What is the risk of second malignant neoplasms after childhood cancer?
Is oral mucositis an inevitable consequence of intensive therapy for hematologic cancers?
Perspectives in the treatment of gastric cancer
EUVIMED